In the face of growing competition and the push for on-demand production, new data-driven opportunities are opening up for the pharmaceutical industry.
For businesses in this sector, the issues of digital transformation overlap with those of a broader transformation in the industry, especially with regard to quality.
Nowadays, the business world is facing a new era of intelligent machines capable of interacting with each other and increasing the volumes and quality of production and distribution processes - an extremely complex world where processes aren’t helped by regulations and bureaucracy.
The SCOR model implemented in the pharmaceutical industry constitutes, for all intents and purposes, a successful attempt to standardize the supply chain.
When it comes to the supply chain, the model lays out a framework involving five parties who interact with each other at various levels:
manufacturers, custodians, intermediate suppliers, transporters and delivery locations (mainly pharmacies and hospitals, but also large-scale wholesalers and drugstores selling only non-prescription products for drugs that can be sold via these channels), in addition to the national health service.
This is where GIB comes into play, with software capable of analyzing data in order to create accurate forecasts for custom manufacturing for the various channels.
In fact, using GIB Suite makes it possible to take account of the connections and constraints related to individual capacities, allowing you to process all types of orders for production and system maintenance with a single centralized solution.
What’s more, the GIB Suite module “Production Planning & Scheduling” helps to maximize throughput and minimize downtimes.
Our GIB solution is completely integrated into SAP and offers all the tools required to make the planning process a success.
Rehabilitation, auxiliary and medicinal products
Cleaning agents, hand sanitizers, Foam soap dispensers
Pharmaceuticals and diagnostics